MH Mooney

469 total citations
13 papers, 412 citations indexed

About

MH Mooney is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, MH Mooney has authored 13 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Oncology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in MH Mooney's work include Diabetes Treatment and Management (10 papers), Peptidase Inhibition and Analysis (8 papers) and Neuropeptides and Animal Physiology (7 papers). MH Mooney is often cited by papers focused on Diabetes Treatment and Management (10 papers), Peptidase Inhibition and Analysis (8 papers) and Neuropeptides and Animal Physiology (7 papers). MH Mooney collaborates with scholars based in United Kingdom, Bangladesh and United States. MH Mooney's co-authors include Peter R. Flatt, Finbarr O’Harte, Victor A. Gault, Patrick Harriott, BD Green, Clifford J. Bailey, Catherine M. Kelly, Nigel Irwin, Brett Greer and Aine McKillop and has published in prestigious journals such as Diabetes, Diabetologia and Metabolism.

In The Last Decade

MH Mooney

13 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MH Mooney United Kingdom 11 323 176 144 138 124 13 412
Suad Efendic Sweden 9 99 0.3× 105 0.6× 120 0.8× 213 1.5× 16 0.1× 11 364
Kerstin Kühn‐Wache Canada 9 199 0.6× 121 0.7× 88 0.6× 161 1.2× 131 1.1× 12 358
Brian M. Moran United Kingdom 10 160 0.5× 52 0.3× 174 1.2× 136 1.0× 37 0.3× 12 334
BD Green United Kingdom 11 298 0.9× 166 0.9× 171 1.2× 160 1.2× 105 0.8× 15 386
Charles Xing United States 8 185 0.6× 98 0.6× 113 0.8× 211 1.5× 88 0.7× 20 424
Rohn Millican United States 6 207 0.6× 38 0.2× 133 0.9× 241 1.7× 18 0.1× 6 399
Monique Lambert Belgium 11 54 0.2× 176 1.0× 123 0.9× 211 1.5× 54 0.4× 24 366
H.U. Demuth Germany 6 117 0.4× 95 0.5× 45 0.3× 60 0.4× 108 0.9× 10 211
Michael Lückmann Denmark 10 148 0.5× 103 0.6× 123 0.9× 268 1.9× 42 0.3× 16 403
Lisa Getty‐Kaushik United States 8 202 0.6× 59 0.3× 131 0.9× 153 1.1× 10 0.1× 8 353

Countries citing papers authored by MH Mooney

Since Specialization
Citations

This map shows the geographic impact of MH Mooney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MH Mooney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MH Mooney more than expected).

Fields of papers citing papers by MH Mooney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MH Mooney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MH Mooney. The network helps show where MH Mooney may publish in the future.

Co-authorship network of co-authors of MH Mooney

This figure shows the co-authorship network connecting the top 25 collaborators of MH Mooney. A scholar is included among the top collaborators of MH Mooney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MH Mooney. MH Mooney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Green, BD, Victor A. Gault, MH Mooney, et al.. (2004). Molecular, cellular and biological characteristics of DPP IV-resistant acetylated analogues of GLP-1.. Diabetic Medicine. 21. 26–26. 1 indexed citations
2.
Green, BD, MH Mooney, Victor A. Gault, et al.. (2004). N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity. Journal of Endocrinology. 180(3). 379–388. 50 indexed citations
3.
4.
5.
Green, BD, Victor A. Gault, MH Mooney, et al.. (2003). Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1(7-36)amide have preserved biological activities in vitro conferring improved glucose-lowering action in vivo. Journal of Molecular Endocrinology. 31(3). 529–540. 34 indexed citations
6.
7.
Gault, Victor A., Peter R. Flatt, Patrick Harriott, et al.. (2003). Improved biological activity of Gly2- and Ser2-substituted analogues of glucose-dependent insulinotrophic polypeptide. Journal of Endocrinology. 176(1). 133–141. 36 indexed citations
8.
McKillop, Aine, Yasser H.A. Abdel‐Wahab, MH Mooney, Finbarr O’Harte, & Peter R. Flatt. (2002). Secretion of glycated insulin from pancreatic beta-cells in diabetes represents a novel aspect of beta-cell dysfunction and glucose toxicity.. PubMed. 28(6 Pt 2). 3S61–9; discussion 3S108. 12 indexed citations
9.
O’Harte, Finbarr, et al.. (2001). Degradation and glycemic effects of His7-glucitol glucagon-like peptide-1(7–36)amide in obese diabetic ob/ob mice. Regulatory Peptides. 96(3). 95–104. 25 indexed citations
10.
O’Harte, Finbarr, MH Mooney, Catherine M. Kelly, & Peter R. Flatt. (2000). Improved glycaemic control in obese diabetic ob/ob mice using N-terminally modified gastric inhibitory polypeptide. Journal of Endocrinology. 165(3). 639–648. 41 indexed citations
11.
Mooney, MH, et al.. (2000). Production and characterization of specific antibodies for evaluation of glycated insulin in plasma and biological tissues. Journal of Endocrinology. 167(1). 153–163. 17 indexed citations
12.
O’Harte, Finbarr, MH Mooney, & Peter R. Flatt. (1998). Glycated gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced insulinotropic activity. Diabetologia. 41. 712–712. 1 indexed citations
13.
O’Harte, Finbarr, MH Mooney, Catherine M. Kelly, & Peter R. Flatt. (1998). Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation.. Diabetes. 47(10). 1619–1624. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suad Efendic Breakdown of academic impact, for papers by Kerstin Kühn‐Wache Breakdown of academic impact, for papers by Brian M. Moran Breakdown of academic impact, for papers by BD Green Breakdown of academic impact, for papers by Charles Xing Breakdown of academic impact, for papers by Rohn Millican Breakdown of academic impact, for papers by Monique Lambert Breakdown of academic impact, for papers by H.U. Demuth Breakdown of academic impact, for papers by Michael Lückmann Breakdown of academic impact, for papers by Lisa Getty‐Kaushik
Rankless by CCL
2026